Reports Q4 revenue $7.2B, consensus $7.12B. “We had an outstanding finish to 2025, driving double-digit sales and adjusted earnings per share growth for the fourth quarter and full year while delivering adjusted operating margin expansion of at least 100 basis points for the second consecutive year,” said Kevin Lobo, CEO of Stryker (SYK). “Having surpassed $25B in revenue, we enter 2026 with significant momentum and are poised to continue delivering growth at the high end of MedTech.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker options imply 3.7% move in share price post-earnings
- Notable companies reporting after market close
- These Are the Stocks Reporting Earnings Today – January 29, 2026
- Midday Fly By: CMS proposal sinks insurers, UnitedHealth reports mixed Q4
- Target upgraded, Stryker downgraded: Wall Street’s top analyst calls